Skip to main content

RxHighlights

A monthly overview of treatment guidelines, important literature and key issues influencing today’s pharmacy and health care environment.

December 2025

Core topics in this month’s edition include:

  • Exdensur (depemokimab) – New drug approval
  • Cablivi® (caplacizumab-yhdp) – Expanded indication
  • Adzenys XR-ODT® (amphetamine) – First-time generic

Download